HIV pre-exposure prophylaxis

BMJ. 2012 Aug 13:345:e5412. doi: 10.1136/bmj.e5412.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-HIV Agents / economics
  • Anti-HIV Agents / therapeutic use*
  • Cost-Benefit Analysis
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / economics
  • Deoxycytidine / therapeutic use
  • Drug Approval
  • Drug Combinations
  • Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
  • HIV Infections / economics
  • HIV Infections / prevention & control*
  • Humans
  • Organophosphorus Compounds / economics
  • Organophosphorus Compounds / therapeutic use*
  • United States
  • United States Food and Drug Administration

Substances

  • Anti-HIV Agents
  • Drug Combinations
  • Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
  • Organophosphorus Compounds
  • Deoxycytidine

Grants and funding